share_log

HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $25 Price Target

HC Wainwright & Co. Reiterates Buy on Milestone Pharmaceuticals, Maintains $25 Price Target

HC Wainwright & Co.重申买入Milestone Pharmicals,维持25美元的目标
Benzinga ·  2023/08/14 11:08

HC Wainwright & Co. analyst Patrick Trucchio reiterates Milestone Pharmaceuticals (NASDAQ:MIST) with a Buy and maintains $25 price target.

HC Wainwright&Co.分析师帕特里克·楚奇奥重申了里程碑制药(纳斯达克:MIST)的买入,并维持25美元的目标价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发